The UNT IBC currently oversees:
- Recombinant DNA and synthetic nucleic acid molecules
- Infectious agents (bacteria, fungi, protozoa, parasites, viruses, prions, etc.)
- All human and non-human primate-derived materials
- Transgenic animals, invertebrates, and/or plants
- All animal-derived materials
- Field studies involving biological sample collection or live animal handling
- Toxins of Biological Origin
- Federally Regulated Select Agents
- Dual Use Research of Concern potential
- Gene transfer or therapy
- Synthetic biology
- International, Federal, and State Transport Regulations
*This list is not exhaustive. For a complete list of research materials that fall
under the purview of IBC, please contact the Biosafety Officer or the IBC Chair.
The IRB and IACUC do not consider biosafety issues during their respective reviews.
They rely on the Institutional Biosafety Committee to perform this aspect of the review.
Contact:
Contact the IBC at: IBCprogram@unt.edu
Biosafety Officer: Dr. Veena Naik: veena.naik@unt.edu